Cancer therapy and polymorphisms of cytochromes P450.

scientific article

Cancer therapy and polymorphisms of cytochromes P450. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1515/CCLM.2000.128
P698PubMed publication ID11097344

P2093author name stringF F Kadlubar
G McClure
S L MacLeod
S Nowell
J Plaxco
J Massengill
A Jazieh
N P Lan
P2860cites workHuman liver microsomal metabolism of paclitaxel and drug interactionsQ28610020
Clinical pharmacokinetics of docetaxel.Q30657347
Modulation of P450-dependent ifosfamide pharmacokinetics: a better understanding of drug activation in vivoQ34749403
Human cytochromes P450: problems and prospectsQ35856204
Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymesQ37362341
CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activityQ38315596
Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4.Q44686949
P433issue9
P304page(s)883-887
P577publication date2000-09-01
P1433published inClinical Chemistry and Laboratory MedicineQ5133754
P1476titleCancer therapy and polymorphisms of cytochromes P450.
P478volume38

Reverse relations

cites work (P2860)
Q37156427Differences in hematotoxicity between male and female patients with Hodgkin lymphoma and other malignancies
Q34606802Effect of the cytochrome P450 2C19 inhibitor omeprazole on the pharmacokinetics and safety profile of bortezomib in patients with advanced solid tumours, non-Hodgkin's lymphoma or multiple myeloma
Q40560358In vitro characterization of the biotransformation of thiocoraline, a novel marine anti-cancer drug
Q40288530In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drug
Q36271954Modulation of oral drug bioavailability: from preclinical mechanism to therapeutic application
Q36221957Personalised medicine for cancer: from drug development into clinical practice
Q36097229Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism
Q44654810The impact of current tobacco use on the outcome of paracetamol poisoning
Q64240769Tumor response to irinotecan is associated with CYP3A5 expression in colorectal cancer

Search more.